Effect of the Application of Trial Inclusion Criteria on the Efficacy of Adalimumab Therapy in a Rheumatoid Arthritis Cohort

I.M. Visman, G.M. Bartelds, W. Ouwerkerk, A.C.J. Ravelli, L.M. Peelen, B.A.C. Dijkmans, M. Boers, M.T. Nurmohamed

Research output: Contribution to journal › Article › Academic › peer-review

Access to Document

@article{d28284ddb2134f3c9b13d28753c0d941,

title = "Effect of the Application of Trial Inclusion Criteria on the Efficacy of Adalimumab Therapy in a Rheumatoid Arthritis Cohort",

author = "I.M. Visman and G.M. Bartelds and W. Ouwerkerk and A.C.J. Ravelli and L.M. Peelen and B.A.C. Dijkmans and M. Boers and M.T. Nurmohamed",

year = "2011",

doi = "10.3899/jrheum.101283",

language = "Undefined/Unknown",

volume = "38",

pages = "1884--1890",

journal = "Journal of Rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology",

number = "9",

}

TY - JOUR

T1 - Effect of the Application of Trial Inclusion Criteria on the Efficacy of Adalimumab Therapy in a Rheumatoid Arthritis Cohort

AU - Visman, I.M.

AU - Bartelds, G.M.

AU - Ouwerkerk, W.

AU - Ravelli, A.C.J.

AU - Peelen, L.M.

AU - Dijkmans, B.A.C.

AU - Boers, M.

AU - Nurmohamed, M.T.

PY - 2011

Y1 - 2011

U2 - 10.3899/jrheum.101283

DO - 10.3899/jrheum.101283

M3 - Article

C2 - 21677005

SN - 0315-162X

VL - 38

SP - 1884

EP - 1890

JO - Journal of Rheumatology

JF - Journal of Rheumatology

IS - 9

ER -